Guobin Fu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA Research and Splicing
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA and protein synthesis mechanisms
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 8
- HER2/EGFR in Cancer Research 4
- Pancreatic and Hepatic Oncology Research 3
-
- Gut microbiota and health 4
- RNA Research and Splicing 3
- Ginseng Biological Effects and Applications 3
- Co-authors
- Ming Yang (4 shared papers)Jinyu Wei (3 shared papers)Liqing Zhou (3 shared papers)Qipeng Yuan (2 shared papers)Juan Shi (2 shared papers)Fang Sun (1 shared paper)Changchun Zhou (1 shared paper)Chao Lü (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Anti-Cancer Drugs (2 papers)Oncotarget (2 papers)JNCI Journal of the National Cancer Institute (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- ChinaSingaporeUnited Kingdom
In The Last Decade
Guobin Fu
26 papers receiving 446 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 226
- Molecular Biology 313
- Oncology 91
- Pulmonary and Respiratory Medicine 54
- Biochemistry 11
Countries citing papers authored by Guobin Fu
This map shows the geographic impact of Guobin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin Fu more than expected).
Fields of papers citing papers by Guobin Fu
This network shows the impact of papers produced by Guobin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin Fu. The network helps show where Guobin Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Guobin Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 147 | |
| 2 | 2016 | 71 | |
| 3 | 2013 | 58 | |
| 4 | 2016 | 31 | |
| 5 | 2015 | 20 | |
| 6 | 2008 | 19 | |
| 7 | 2012 | 17 | |
| 8 | 2022 | 13 | |
| 9 | 2009 | 10 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 6 | |
| 12 | 2019 | 6 | |
| 13 | 2022 | 6 | |
| 14 | 2022 | 6 | |
| 15 | 2024 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 3 |
About Guobin Fu
Guobin Fu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 31 papers that have together received 448 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), HER2/EGFR in Cancer Research (4 papers), Gut microbiota and health (4 papers), Lung Cancer Treatments and Mutations (4 papers), RNA Research and Splicing (3 papers), Cancer-related molecular mechanisms research (3 papers), Ginseng Biological Effects and Applications (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Cancer Research (226 citations), Molecular Biology (313 citations), Oncology (91 citations), Pulmonary and Respiratory Medicine (54 citations) and Biochemistry (11 citations). Guobin Fu has collaborated with scholars based in China, Singapore and United Kingdom. Frequent co-authors include Ming Yang, Jinyu Wei, Liqing Zhou, Qipeng Yuan, Juan Shi, Fang Sun, Changchun Zhou, Chao Lü, Xiaojiao Zhang and Tingliang Wang. Their work appears in journals such as Frontiers in Immunology, Anti-Cancer Drugs, Oncotarget, JNCI Journal of the National Cancer Institute and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.